BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Prozac
,
rs4950928
,
EGFR
,
HIV infection
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
gp inhibitor
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Liver, breast and endometrial cell lines exposed to 34 toxicological compounds
Fibroblasts of normal cardiac ventricles treated with prolyl tRNA synthetase inhibitor halofuginone
Embryonic kidney HEK293 cells treated with senexin B and TNF
Endometrial adenocarcinoma Ishikawa cells in a dosage and time treatment course with Genistein
Induced pluripotent stem cells, embryonic stem cells and fibroblasts in single-cell or bulk RNA-Seq
Explore Curated Studies Results
Literature
Most Relevant Literature
Adenosine kinase inhibitor GP515 improves experimental colitis in mice.
Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor.
The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine.
Adenosine kinase inhibitor GP515 attenuates hepatic leukocyte adhesion after hemorrhagic hypotension…
Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and va…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma
HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study
The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)
Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhib…
PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ